FJ3 Stock Overview
Provides packaging materials, medical/pharmaceutical packaging materials, and materials for the functional fields in Japan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
ZACROS Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥25.00 |
| 52 Week High | JP¥27.40 |
| 52 Week Low | JP¥23.00 |
| Beta | 0.52 |
| 1 Month Change | -1.57% |
| 3 Month Change | -6.02% |
| 1 Year Change | 3.31% |
| 3 Year Change | -20.89% |
| 5 Year Change | -11.97% |
| Change since IPO | 125.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| FJ3 | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 2.5% | 1.3% | 0.5% |
| 1Y | 3.3% | 6.3% | 15.3% |
Return vs Industry: FJ3 exceeded the German Chemicals industry which returned 1.7% over the past year.
Return vs Market: FJ3 underperformed the German Market which returned 13.7% over the past year.
Price Volatility
| FJ3 volatility | |
|---|---|
| FJ3 Average Weekly Movement | 3.4% |
| Chemicals Industry Average Movement | 4.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: FJ3 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: FJ3's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1914 | 2,664 | Taku Shimoda | www.zacros.co.jp |
ZACROS Corporation provides packaging materials, medical/pharmaceutical packaging materials, and materials for the functional fields in Japan and internationally. It operates through four segments: Wellness Business, Environmental Solutions Business, Electronic Materials Business, and Industrial Infrastructure Business. The company offers wellness products, including BioPhas, a customized service that is used in single-use products for biopharmaceuticals manufacturing; MediTect IV Bag, an infusion bags; and Total Thrombus formation Analysis System, a flow chamber system.
ZACROS Corporation Fundamentals Summary
| FJ3 fundamental statistics | |
|---|---|
| Market cap | €471.56m |
| Earnings (TTM) | €29.87m |
| Revenue (TTM) | €925.58m |
15.8x
P/E Ratio0.5x
P/S RatioIs FJ3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FJ3 income statement (TTM) | |
|---|---|
| Revenue | JP¥145.69b |
| Cost of Revenue | JP¥112.71b |
| Gross Profit | JP¥32.98b |
| Other Expenses | JP¥28.28b |
| Earnings | JP¥4.70b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 252.71 |
| Gross Margin | 22.64% |
| Net Profit Margin | 3.23% |
| Debt/Equity Ratio | 1.3% |
How did FJ3 perform over the long term?
See historical performance and comparisonDividends
2.7%
Current Dividend Yield38%
Payout RatioDoes FJ3 pay a reliable dividends?
See FJ3 dividend history and benchmarks| ZACROS dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 23 2025 |
| Days until Ex dividend | 49 days |
| Days until Dividend pay date | 136 days |
Does FJ3 pay a reliable dividends?
See FJ3 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 08:22 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ZACROS Corporation is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mitsuharu Watanabe | Daiwa Securities Co. Ltd. |
| Katsuhiko Ishibashi | Ichiyoshi Research Institute Inc. |
| Shigekazu Ishida | Marusan Securities Co. Ltd. |